
USFDA okays Lupin Prucalopride Tablets for chronic idiopathic constipation
Mumbai: Global pharma major Lupin Limited has received a green light from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Prucalopride Tablets, 1 mg, and 2 mg for the treatment of chronic idiopathic …